Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 638.29 Million CNY | 12.15% |
| 2022 | 569.14 Million CNY | 15.4% |
| 2021 | 493.19 Million CNY | -14.5% |
| 2020 | 576.86 Million CNY | -4.99% |
| 2019 | 607.17 Million CNY | -7.79% |
| 2018 | 658.48 Million CNY | -4.67% |
| 2017 | 690.76 Million CNY | -8.52% |
| 2016 | 755.08 Million CNY | 91.47% |
| 2015 | 394.36 Million CNY | -12.07% |
| 2014 | 448.51 Million CNY | 64.5% |
| 2013 | 272.65 Million CNY | 16.18% |
| 2012 | 234.68 Million CNY | 3.86% |
| 2011 | 225.95 Million CNY | -40.54% |
| 2010 | 380.02 Million CNY | -21.75% |
| 2009 | 485.66 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 754.92 Million CNY | 0.0% |
| 2024 Q1 | 754.92 Million CNY | 18.27% |
| 2023 Q3 | 638.29 Million CNY | 4.34% |
| 2023 Q4 | 638.29 Million CNY | 0.0% |
| 2023 FY | 638.29 Million CNY | 12.15% |
| 2023 Q1 | 611.77 Million CNY | 7.49% |
| 2023 Q2 | 611.77 Million CNY | 0.0% |
| 2022 Q3 | 569.14 Million CNY | 8.13% |
| 2022 Q1 | 526.37 Million CNY | 6.73% |
| 2022 Q4 | 569.14 Million CNY | 0.0% |
| 2022 FY | 569.14 Million CNY | 15.4% |
| 2022 Q2 | 526.37 Million CNY | 0.0% |
| 2021 FY | 493.19 Million CNY | -14.5% |
| 2021 Q4 | 493.19 Million CNY | 0.0% |
| 2021 Q3 | 493.19 Million CNY | -11.33% |
| 2021 Q2 | 556.24 Million CNY | 0.0% |
| 2021 Q1 | 556.24 Million CNY | -3.57% |
| 2020 Q4 | 576.86 Million CNY | 0.0% |
| 2020 Q3 | 576.86 Million CNY | -14.37% |
| 2020 Q1 | 673.68 Million CNY | 10.95% |
| 2020 Q2 | 673.68 Million CNY | 0.0% |
| 2020 FY | 576.86 Million CNY | -4.99% |
| 2019 Q1 | 547.22 Million CNY | -16.9% |
| 2019 FY | 607.17 Million CNY | -7.79% |
| 2019 Q2 | 547.22 Million CNY | 0.0% |
| 2019 Q4 | 607.17 Million CNY | 0.0% |
| 2019 Q3 | 607.17 Million CNY | 10.96% |
| 2018 Q3 | 633.22 Million CNY | 0.22% |
| 2018 Q2 | 631.85 Million CNY | 3.99% |
| 2018 Q1 | 607.62 Million CNY | -12.04% |
| 2018 FY | 658.48 Million CNY | -4.67% |
| 2018 Q4 | 658.48 Million CNY | 3.99% |
| 2017 Q1 | 583.34 Million CNY | -22.74% |
| 2017 Q4 | 690.76 Million CNY | 3.86% |
| 2017 Q3 | 665.12 Million CNY | 9.16% |
| 2017 Q2 | 609.3 Million CNY | 4.45% |
| 2017 FY | 690.76 Million CNY | -8.52% |
| 2016 Q2 | 493.98 Million CNY | 0.0% |
| 2016 FY | 755.08 Million CNY | 91.47% |
| 2016 Q4 | 755.08 Million CNY | 3.88% |
| 2016 Q3 | 726.92 Million CNY | 47.15% |
| 2016 Q1 | 493.98 Million CNY | 25.26% |
| 2015 Q3 | 371.88 Million CNY | -29.16% |
| 2015 Q1 | 524.93 Million CNY | 17.04% |
| 2015 Q2 | 524.93 Million CNY | 0.0% |
| 2015 FY | 394.36 Million CNY | -12.07% |
| 2015 Q4 | 394.36 Million CNY | 6.05% |
| 2014 Q1 | 343 Million CNY | 25.8% |
| 2014 Q4 | 448.51 Million CNY | 0.0% |
| 2014 Q3 | 448.51 Million CNY | 27.27% |
| 2014 FY | 448.51 Million CNY | 64.5% |
| 2014 Q2 | 352.4 Million CNY | 2.74% |
| 2013 Q2 | 230.42 Million CNY | 2.85% |
| 2013 Q4 | 272.65 Million CNY | 3.57% |
| 2013 FY | 272.65 Million CNY | 16.18% |
| 2013 Q1 | 224.04 Million CNY | -4.53% |
| 2013 Q3 | 263.25 Million CNY | 14.25% |
| 2012 Q3 | 211.11 Million CNY | 19.61% |
| 2012 FY | 234.68 Million CNY | 3.86% |
| 2012 Q4 | 234.68 Million CNY | 11.17% |
| 2012 Q2 | 176.5 Million CNY | 0.0% |
| 2011 FY | 225.95 Million CNY | -40.54% |
| 2011 Q2 | 216.18 Million CNY | 0.0% |
| 2011 Q4 | 225.95 Million CNY | 0.0% |
| 2010 Q4 | 380.02 Million CNY | 0.0% |
| 2010 FY | 380.02 Million CNY | -21.75% |
| 2009 FY | 485.66 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Healthwise Holdings Limited | 145.27 Million HKD | -339.381% |
| Tycoon Group Holdings Limited | 445.4 Million HKD | -43.307% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 413.75 Million HKD | -54.27% |